Effectiveness of Tralokinumab for Upadacitinib-Refractory Atopic Dermatitis: 48-week Retrospective Study

Name: Effectiveness of Tralokinumab for Upadacitinib-Refractory Atopic Dermatitis: 48-week Retrospective Study
Creator: Nihon Ika Daigaku Chiba Hokuso Byoin; Nihon Ika Daigaku Fuzoku Byoin
Published: 2026-04-09T12:27:02+08:00

Mendeley Data2026-04-09 收录

数据链接：

https://data.mendeley.com/datasets/y98j2b9nw3/1 数据链接链接失效反馈

官方服务：

资源简介：

Supplementary Table 1. Baseline demographic and disease characteristics of patients with atopic dermatitis (n = 24)

补充表1. 特应性皮炎（atopic dermatitis）患者的基线人口统计学特征与疾病特征（n=24）

提供机构：

Nihon Ika Daigaku Chiba Hokuso Byoin; Nihon Ika Daigaku Fuzoku Byoin

Effectiveness of Tralokinumab for Upadacitinib-Refractory Atopic Dermatitis: 48-week Retrospective Study

资源简介：

相关数据集